OraSure Technologies (OSUR) Gross Profit Margin: History & Chart

OraSure Technologies, Inc.(OSUR)

Medical - Instruments & Supplies · Bethlehem, PA

$3.89-0.22 (-5.39%)

Delayed quote: Oct 6, 2026, 12:15 PM EDT

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.

Bethlehem, PA

500 employees

www.orasure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Carrie Eglinton Manner

View full financials

OSUR Gross Margin Metrics

GROSS MARGIN

41.38%

GROSS MARGIN AVG TTM

41.49%

GROSS MARGIN AVG 3Y

43.07%

GROSS MARGIN AVG 5Y

41.28%

GROSS MARGIN AVG 10Y

51.55%

GROSS MARGIN AVG 15Y

55.40%

GROSS MARGIN AVG 20Y

57.20%

CURRENT VS TTM AVG

-0.27%

CURRENT VS 3Y AVG

-3.93%

CURRENT VS 5Y AVG

+0.24%

CURRENT VS 10Y AVG

-19.73%

CURRENT VS 15Y AVG

-25.30%

CURRENT VS 20Y AVG

-27.66%

SECTOR MEDIAN · HEALTHCARE

40.38%

median of 740 covered companies

CURRENT VS SECTOR MEDIAN

+2.48%

vs the sector median at left

NAME	MARKET CAP	GROSS MARGIN	TTM	3Y	5Y
OraSure Technologies, Inc. (OSUR)	$267.70M	41.38%	41.49%	43.07%	41.28%
EyePoint Pharmaceuticals, Inc. (EYPT)vs ›	$267.87M	93.41%	92.41%	88.66%	85.93%
Eupraxia Pharmaceuticals Inc. (EPRX)vs ›	$266.10M	0.00%	0.00%	0.00%	0.00%
Inhibikase Therapeutics, Inc. (IKT)vs ›	$266.05M	0.00%	0.00%	-1258.31%	-887.92%
Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›	$262.65M	0.00%	0.00%	25.00%	50.00%
Palisade Bio, Inc. (PALI)vs ›	$261.58M	0.00%	0.00%	25.00%	16.67%
Scribe Therapeutics Inc. (SCTX)vs ›	$274.77M	N/A	N/A	N/A	N/A
Rocket Pharmaceuticals, Inc. (RCKT)vs ›	$275.17M	0.00%	0.00%	0.00%	0.00%
Fate Therapeutics, Inc. (FATE)vs ›	$276.62M	-94.12%	-431.85%	-231.35%	-189.25%
Anika Therapeutics, Inc. (ANIK)vs ›	$258.67M	62.16%	59.97%	63.15%	60.27%

NAME

MARKET CAP

GROSS MARGIN

TTM

OraSure Technologies, Inc. (OSUR)

$267.70M

41.38%

41.49%

43.07%

41.28%

EyePoint Pharmaceuticals, Inc. (EYPT)vs ›

$267.87M

93.41%

92.41%

88.66%

85.93%

Eupraxia Pharmaceuticals Inc. (EPRX)vs ›

$266.10M

0.00%

Inhibikase Therapeutics, Inc. (IKT)vs ›

$266.05M

0.00%

-1258.31%

-887.92%

Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›

$262.65M

0.00%

25.00%

50.00%

Palisade Bio, Inc. (PALI)vs ›

$261.58M

0.00%

25.00%

16.67%

Scribe Therapeutics Inc. (SCTX)vs ›

$274.77M

N/A

Rocket Pharmaceuticals, Inc. (RCKT)vs ›

$275.17M

0.00%

Fate Therapeutics, Inc. (FATE)vs ›

$276.62M

-94.12%

-431.85%

-231.35%

-189.25%

Anika Therapeutics, Inc. (ANIK)vs ›

$258.67M

62.16%

59.97%

63.15%

60.27%

Gross Margin FAQ

What is the gross margin for OraSure Technologies, Inc. (OSUR)?

The gross margin for OSUR stock is 41.38%.

Is OraSure Technologies, Inc.'s gross margin high or low?

The gross margin of 41.38% is in line with its 5-year average of 41.28%, around the middle of its 5-year range (30.86%–53.25%).

What is the TTM average gross margin for OraSure Technologies, Inc. (OSUR)?

The TTM average gross margin for OSUR stock is 41.49%.

What is the 3Y average gross margin for OraSure Technologies, Inc. (OSUR)?

The 3Y average gross margin for OSUR stock is 43.07%.

What is the 5Y average gross margin for OraSure Technologies, Inc. (OSUR)?

The 5Y average gross margin for OSUR stock is 41.28%.

What is the 10Y average gross margin for OraSure Technologies, Inc. (OSUR)?

The 10Y average gross margin for OSUR stock is 51.55%.

What is the 15Y average gross margin for OraSure Technologies, Inc. (OSUR)?

The 15Y average gross margin for OSUR stock is 55.40%.

What is the 20Y average gross margin for OraSure Technologies, Inc. (OSUR)?

The 20Y average gross margin for OSUR stock is 57.20%.

DATE	GROSS MARGIN
2026-06-30	43.46%
2026-03-31	37.44%
2025-12-31	40.98%
2025-09-30	43.46%
2025-06-30	42.12%
2025-03-31	41.09%
2024-12-31	36.87%
2024-09-30	42.78%
2024-06-30	47.07%
2024-03-31	44.88%
2023-12-31	46.97%
2023-09-30	49.72%
2023-06-30	30.86%
2023-03-31	42.47%
2022-12-31	40.48%
2022-09-30	39.94%
2022-06-30	34.65%
2022-03-31	35.89%
2021-12-31	42.68%
2021-09-30	39.82%
2021-06-30	53.25%
2021-03-31	65.42%
2020-12-31	60.75%
2020-09-30	63.09%
2020-06-30	59.00%
2020-03-31	51.05%
2019-12-31	60.08%
2019-09-30	60.15%
2019-06-30	64.44%
2019-03-31	60.02%
2018-12-31	69.07%
2018-09-30	62.21%
2018-06-30	59.36%
2018-03-31	58.27%
2017-12-31	54.83%
2017-09-30	58.24%
2017-06-30	63.41%
2017-03-31	62.40%
2016-12-31	67.48%
2016-09-30	70.31%
2016-06-30	67.24%
2016-03-31	69.83%
2015-12-31	67.72%
2015-09-30	69.22%
2015-06-30	68.11%
2015-03-31	62.75%
2014-12-31	62.68%
2014-09-30	67.18%
2014-06-30	60.66%
2014-03-31	59.17%
2013-12-31	59.54%
2013-09-30	60.53%
2013-06-30	59.58%
2013-03-31	56.84%
2012-12-31	59.84%
2012-09-30	62.80%
2012-06-30	64.99%
2012-03-31	65.57%
2011-12-31	61.61%
2011-09-30	62.60%
2011-06-30	64.31%
2011-03-31	64.70%
2010-12-31	63.58%
2010-09-30	62.07%
2010-06-30	63.37%
2010-03-31	63.55%
2009-12-31	59.25%
2009-09-30	64.34%
2009-06-30	57.20%
2009-03-31	63.58%
2008-12-31	55.94%
2008-09-30	57.62%
2008-06-30	58.82%
2008-03-31	58.84%
2007-12-31	58.20%
2007-09-30	59.62%
2007-06-30	63.05%
2007-03-31	62.28%
2006-12-31	64.81%
2006-09-30	63.91%
2006-06-30	62.81%
2006-03-31	63.08%
2005-12-31	60.06%
2005-09-30	64.42%
2005-06-30	54.27%
2005-03-31	59.75%
2004-12-31	59.84%
2004-09-30	59.64%
2004-06-30	58.19%
2004-03-31	58.17%
2003-12-31	60.79%
2003-09-30	61.26%
2003-06-30	60.32%
2003-03-31	58.42%
2002-12-31	58.24%
2002-09-30	58.68%

DATE

GROSS MARGIN

2026-06-30

43.46%

2026-03-31

37.44%

2025-12-31

40.98%

2025-09-30

43.46%

2025-06-30

42.12%

2025-03-31

41.09%

2024-12-31

36.87%

2024-09-30

42.78%

2024-06-30

47.07%

2024-03-31

44.88%

2023-12-31

46.97%

2023-09-30

49.72%

2023-06-30

30.86%

2023-03-31

42.47%

2022-12-31

40.48%

2022-09-30

39.94%

2022-06-30

34.65%

2022-03-31

35.89%

2021-12-31

42.68%

2021-09-30

39.82%

2021-06-30

53.25%

2021-03-31

65.42%

2020-12-31

60.75%

2020-09-30

63.09%

2020-06-30

59.00%

2020-03-31

51.05%

2019-12-31

60.08%

2019-09-30

60.15%

2019-06-30

64.44%

2019-03-31

60.02%

2018-12-31

69.07%

2018-09-30

62.21%

2018-06-30

59.36%

2018-03-31

58.27%

2017-12-31

54.83%

2017-09-30

58.24%

2017-06-30

63.41%

2017-03-31

62.40%

2016-12-31

67.48%

2016-09-30

70.31%

2016-06-30

67.24%

2016-03-31

69.83%

2015-12-31

67.72%

2015-09-30

69.22%

2015-06-30

68.11%

2015-03-31

62.75%

2014-12-31

62.68%

2014-09-30

67.18%

2014-06-30

60.66%

2014-03-31

59.17%

2013-12-31

59.54%

2013-09-30

60.53%

2013-06-30

59.58%

2013-03-31

56.84%

2012-12-31

59.84%

2012-09-30

62.80%

2012-06-30

64.99%

2012-03-31

65.57%

2011-12-31

61.61%

2011-09-30

62.60%

2011-06-30

64.31%

2011-03-31

64.70%

2010-12-31

63.58%

2010-09-30

62.07%

2010-06-30

63.37%

2010-03-31

63.55%

2009-12-31

59.25%

2009-09-30

64.34%

2009-06-30

57.20%

2009-03-31

63.58%

2008-12-31

55.94%

2008-09-30

57.62%

2008-06-30

58.82%

2008-03-31

58.84%

2007-12-31

58.20%

2007-09-30

59.62%

2007-06-30

63.05%

2007-03-31

62.28%

2006-12-31

64.81%

2006-09-30

63.91%

2006-06-30

62.81%

2006-03-31

63.08%

2005-12-31

60.06%

2005-09-30

64.42%

2005-06-30

54.27%

2005-03-31

59.75%

2004-12-31

59.84%

2004-09-30

59.64%

2004-06-30

58.19%

2004-03-31

58.17%

2003-12-31

60.79%

2003-09-30

61.26%

2003-06-30

60.32%

2003-03-31

58.42%

2002-12-31

58.24%

2002-09-30

58.68%

Gross Margin: 41.38%

OSUR Gross Margin

OSUR Average Gross Margin Chart

OSUR Current vs Average Gross Margin Chart

OSUR Gross Margin Metrics

OSUR Competitors' Gross Margin

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin FAQ

OSUR Gross Margin History

Related Metrics